Product Program year 2020 Source: CMS Open Payments

Cleviprex 25Mg/50Ml

Drug Cardiovascular

NDC 10122-610-10

Open in the dashboard

General payments

$29,526

1,274 payments

Research payments

$0

0 payments

Through program year 2020, $29,526 in general payments and $0 in research payments were reported against Cleviprex 25Mg/50Ml (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $29,526 1,274

Breakdown

Who paid General payments · program year 2020
  1. Chiesi USA, Inc. $29,526 1,274 payments
Top recipients General payments · program year 2020
  1. Todd Horowitz Anesthesiology · Delray Beach, FL $1,887 6% · 7 payments
  2. Scott Brehaut Family Medicine · Clinton, NY $1,552 5% · 6 payments
  3. David Rose Neurology · Tampa, FL $1,310 4% · 4 payments
  4. Edwin Avery Anesthesiology · Cleveland, OH $803 3% · 4 payments
  5. Amir Piracha Cardiovascular Disease · Louisville, KY $215 <1% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Anesthesiology $11,165 38% · 307 practitioners
  2. Cardiovascular Disease Internal Medicine $3,382 12% · 119 practitioners
  3. Interventional Cardiology Internal Medicine $2,567 9% · 85 practitioners
  4. Neurology Psychiatry & Neurology $1,836 6% · 23 practitioners
  5. Family Medicine $1,761 6% · 9 practitioners

The top 5 of 46 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Florida $4,663 16% · 59 recipients
  2. New York $4,289 15% · 118 recipients
  3. Kentucky $2,555 9% · 64 recipients
  4. Pennsylvania $2,492 8% · 70 recipients
  5. New Jersey $1,951 7% · 82 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,274 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record